Skip to content
Use caution Drug recall · FDA · Published October 15, 2026

Ritedose Recalls Formoterol Fumarate Inhalation Solution Due to Impurities

Ritedose recalls Formoterol Fumarate Inhalation Solution due to failed impurity specifications. Check lot 25BL0 and NDCs before use.

🇺🇸 FDA recall #D-0073-2027DrugRitedose ›
✎ GovInfoNow plain-language explainer

The Ritedose Corporation is recalling Formoterol Fumarate Inhalation Solution because the product failed impurity and degradation specifications. The recall affects cartons of 30 and 60 individually wrapped vials distributed nationwide. No specific remedy or injury reports are listed in the record. Read more at govinfonow.com/recall/2084714-the-ritedose-corporation-recalls-formoterol-fumarate-inhalation-solution-20mcg-2ml.

Source Summary by GovInfoNow · govinfonow.com/recall/2084714-the-ritedose-corporation-recalls-formoterol-fumarate-inhalation-solution-20mcg-2ml · Updated November 11, 2026 · FDA enforcement record: FDA #D-0073-2027

Cite this page

“Ritedose Recalls Formoterol Fumarate Inhalation Solution Due to Impurities.” GovInfoNow, updated November 11, 2026. https://govinfonow.com/recall/2084714-the-ritedose-corporation-recalls-formoterol-fumarate-inhalation-solution-20mcg-2ml. Based on FDA recall #D-0073-2027 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0073-2027%22&limit=1).

The Food and Drug Administration announced on Oct. 15, 2026, that The Ritedose Corporation is recalling Formoterol Fumarate Inhalation Solution due to failed impurity specifications. Owners should contact the company for a refund.

How to tell if you have it

  • Brand: Ritedose
  • Product: Formoterol Fumarate Inhalation Solution, 20mcg/2mL
  • NDC 76204-030-01 (cartons of 30 vials)
  • NDC 76204-030-02 (cartons of 60 vials)
  • Lot: 25BL0
  • Expiration date: 02/28/2027

The hazard

The recall addresses failed impurity and degradation specifications in the inhalation solution. The FDA classified this as a Class II recall.

Context

GovInfoNow's records show The Ritedose Corporation has two other recalls on record since April 1, 2022. Other recent recalls of similar products include Sun Pharmaceutical Fluocinolone Acetonide Solution Recall (Dec. 30, 2025), Novadoz Glycopyrrolate Oral Solution Recall (Dec. 15, 2025), and Cipla Recalls Fosfomycin Tromethamine Granules Due to Impurities (Sept. 18, 2026).

How to tell if you have this one

Check if you have Formoterol Fumarate Inhalation Solution, 20mcg/2mL, manufactured by Ritedose Pharmaceuticals, LLC. Look for Lot number 25BL0 and expiration date 02/28/2027. Verify the NDC is either 76204-030-01 (cartons of 30) or 76204-030-02 (cartons of 60).

  • Brand
    Ritedose
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Your Product Details

    Verify if your inhalation solution matches the recalled lot number 25BL0 and NDCs 76204-030-01 or 76204-030-02.

  2. Consult Your Healthcare Provider

    Contact your doctor or pharmacist for guidance on what to do with the recalled medication, as no specific remedy is provided in the record.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide within the U.S” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 20 days after the firm started it.

1. Firm started the recall: Oct 15, 202612. FDA classified it Class II: Oct 23, 202623. Published in FDA’s Enforcement Report: Nov 4, 202634. Added to GovInfoNow: Nov 10, 202642026
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. Added to GovInfoNow

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0073-2027 (October 15, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0073-2027 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on November 11, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA